Plain-English translation of NCT06216171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two approaches to treating head and neck cancer with radiation. One group receives standard radiation therapy guided by imaging, while the other receives adaptive radiotherapy—a newer approach where your radiation dose is adjusted each day based on how your body and tumor have changed. The goal is to see if this personalized approach reduces side effects like difficulty swallowing while treating the cancer effectively.
Recent research suggests that personalizing radiation therapy could reduce damage to the structures involved in swallowing and improve quality of life after treatment. This trial will test whether adapting the treatment plan day-by-day can deliver these improvements compared to standard radiation therapy.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either standard radiation therapy with imaging guidance or adaptive radiation therapy that adjusts to your anatomy each day. Both groups will undergo the same general radiation schedule for head and neck cancer treatment. The adaptive group will have additional imaging and planning by radiation specialists on each treatment day to fine-tune the dose. Your swallowing function and quality of life will be monitored throughout and after treatment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Germany